{"disease":{"id":"disease-caused-by-severe-acute-respiratory-syndrome-coronavirus-2","name":"Disease caused by Severe acute respiratory syndrome coronavirus 2","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":3,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"remdesivir","indication_name":"Disease caused by Severe acute respiratory syndrome coronavirus 2","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Veklury","generic_name":"remdesivir","company_name":"Gilead Sciences","drug_phase":"marketed","molecular_target":"SARS-CoV-2 RNA polymerase","drug_class":"Nucleotide analog RNA polymerase inhibitor","quality_score":79,"revenue":"2200","mechanism":"Remdesivir is an antiviral nucleotide analog RNA polymerase inhibitor with activity against SARS-CoV-2."},{"drug_id":"ensitrelvir","indication_name":"Disease caused by Severe acute respiratory syndrome coronavirus 2","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Xocova","generic_name":"ENSITRELVIR","company_name":"Shionogi & Co., Ltd.","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":24,"revenue":"400","mechanism":""},{"drug_id":"veklury","indication_name":"Disease caused by Severe acute respiratory syndrome coronavirus 2","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Veklury","company_name":"ANRS, Emerging Infectious Diseases","drug_phase":"marketed","molecular_target":"NS5, Replicase polyprotein 1ab","drug_class":"Nucleoside analog prodrug","quality_score":17,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":3,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04712110","title":"A Study of TAK-019 in Healthy Japanese Adults (COVID-19)","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"Takeda","has_results":true},{"nct_id":"NCT05115045","title":"Plasma SARS-CoV-2 RNA Levels in Critically Ill COVID-19 Patients","phase":"","overall_status":"COMPLETED","enrollment_count":122,"lead_sponsor_name":"Hopital of Melun","has_results":false},{"nct_id":"NCT05197686","title":"Early-initiated High Flow Oxygen Therapy vs Conventional Oxygen Therapy Among Patients With ARDS in the Course of SARS-CoV2 Pneumonia.","phase":"NA","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Pomeranian Medical University Szczecin","has_results":false},{"nct_id":"NCT05677893","title":"A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of Inhaled MBS-COV (SNS812) in Healthy Participants","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":44,"lead_sponsor_name":"Oneness Biotech Co., Ltd.","has_results":true},{"nct_id":"NCT04935450","title":"Pulmonary Inflammation in COVID-19 ARDS","phase":"","overall_status":"UNKNOWN","enrollment_count":25,"lead_sponsor_name":"Hospital Universitario Ramon y Cajal","has_results":false},{"nct_id":"NCT04969991","title":"Study of Varespladib in Patients Hospitalized With Severe COVID-19","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":18,"lead_sponsor_name":"Ophirex, Inc.","has_results":true}],"total":6},"guidelines":[],"source":"Drug Landscape verified database"}